Related Experiment Videos
Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics
R R Williams1, S C Hunt, M C Schumacher
1Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City.
Insights
Accurate diagnosis of familial hypercholesterolemia (FH) requires new screening criteria. These criteria differ for the general population versus relatives of known FH cases, improving early detection of this serious genetic disorder.
Area of Science:
- Cardiovascular Genetics
- Clinical Lipidology
- Public Health Screening
Background:
- Familial hypercholesterolemia (FH) is an inherited disorder leading to severely elevated LDL cholesterol and premature cardiovascular disease.
- Existing cholesterol screening criteria often misdiagnose FH in both general populations and family screening settings.
- Accurate and genetically validated criteria are crucial for early FH diagnosis and intervention.
Purpose of the Study:
- To develop distinct, practical screening criteria for heterozygous familial hypercholesterolemia (FH).
- To address the underdiagnosis and overdiagnosis issues with previous FH screening guidelines.
- To provide age- and setting-specific total and LDL cholesterol thresholds for FH diagnosis.
Main Methods:
- Application of the statistical concept of a priori probabilities.
- Derivation of two distinct sets of screening criteria: one for general population screening and another for first-degree relatives of confirmed FH cases.
- Development of detailed tables with specific total and LDL cholesterol values for different age groups and screening contexts.
Main Results:
- New criteria show significant differences based on screening setting; for example, a total cholesterol of 310 mg/dl indicates FH in 95% of relatives but only 4% of the general population.
- Recommended population screening criteria: Total cholesterol > 360 mg/dl (age 40+) or > 270 mg/dl (youth).
- Recommended criteria for first-degree relatives: Total cholesterol > 290 mg/dl (age 40+) or > 220 mg/dl (youth).
Conclusions:
- The derived screening criteria improve the accuracy of diagnosing heterozygous FH in diverse populations.
- Tailoring criteria to the screening context (general population vs. family members) is essential for effective FH case finding.
- Implementation of these criteria can facilitate earlier diagnosis, enabling timely treatment to prevent coronary atherosclerosis.
Abstract:
Heterozygous familial hypercholesterolemia (FH) is a serious disorder causing twice normal low-density lipoprotein cholesterol levels early in childhood and very early coronary disease in both men and women. Treatment with multiple medications and diet can normalize cholesterol levels in many persons with FH and prevent or delay the development of coronary atherosclerosis. Thus, there is a need for accurate and genetically validated criteria for the early diagnosis of heterozygous FH. Previously published blood cholesterol criteria greatly underdiagnosed new cases of FH among members of known families with FH in Utah and overdiagnosed FH among participants of general population screening, revealing the need for different cholesterol screening criteria in persons from these 2 different settings. The statistical concept of a priori probabilities was applied to derive 2 sets of practical screening criteria: one for persons participating in general population screening studies and another for close relatives of confirmed FH cases, showing dramatic differences. At a cholesterol level of 310 mg/dl, only 4% of persons in the general population would have FH but 95% of persons who were first-degree relatives of known cases would have FH. Detailed tables were derived to provide practical total and low-density lipoprotein blood cholesterol screening criteria for diagnosing FH in different screening settings and specific age groups. In population screening the new FH criteria require a total cholesterol > 360 mg/dl for age 40+ (or 270 mg/dl in youth). Among first-degree relatives of confirmed cases in families with FH, the new total cholesterol criteria are much lower (> 290 mg/dl for age 40+, > 220 mg/dl for youth).(ABSTRACT TRUNCATED AT 250 WORDS)